Signos Raises 20 Million to Expand AI Health Data Tracking Amid GLP1 Weight Loss Surge Stellantis Turnaround Prediction Market Regulation Oura IPO Key Morning Market Developments President Trump Drops 10B IRS Lawsuit as DOJ Creates 18B Lawfare Compensation Fund Microsoft Shares Decline Historical SellOffs Have Often Preceded Recoveries Bitcoin and Ethereum Decline on Macro Worries and ETF Outflows Amid 400 Million Crypto Liquidation Sensex Nifty Trade Volatile Hind Zinc SBI Force Motors Lead Activity IHG Q4 2025 Earnings EPS Misses Estimates Amid Modest Stock Uptick ZENA Q4 2025 Earnings Massive EPS Miss Without Revenue Disclosure as Stock Surges 511 Atlanticus Holdings ATLC Q1 2026 Earnings EPS Surges Past Estimates with 258 Beat Odyssey Marine Exploration Inc OMEX Q1 2016 Earnings Surprise Profit as Revenue Remains Elusive Western Midstream Partners Q1 2026 Earnings EPS Beats Estimates by 1391 Stock Rises Pyxis Oncology Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction Destiny Tech100 Inc DXYZ Gains 219 as Shares Approach Key Resistance Zone Certara Stock Slides Marginally as Traders Eye Support Near 495 ZOOZ Strategy Ltd ZOOZ Edges Higher Toward Key Resistance at 033 Star Equity Holdings STRR Edges Higher Testing Key Resistance Near 1211 Nuveen Variable Rate Preferred Income Fund NPFD Holds Steady Near 1879 in LowVolume Session TakeTwo Stock Drops as Game Publisher Provides Conservative Sales Outlook for GTA 6 PODC Q1 2026 Earnings Narrower Than Expected Loss Signals Improving Cost Discipline Apex Treasury Corporation APXT Holds Steady Near Resistance as Trading Volume Remains Moderate Beijings Strategic Bet on Russia May Yield LongTerm Payoff Amid OneSided Dynamic PBR Q1 2026 Earnings Earnings Miss Amid Operational Headwinds SpaceX IPO Speculation Nvidia Earnings and Bezos on AI Bubble Key Market Insights URI Q1 2026 Earnings EPS Beats Estimates but Stock Edges Lower EWCZ Q4 2025 Earnings EPS Beat Driven by Strong Operational Execution ZVRA Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response PTHS Q1 2026 Earnings Pelthos Therapeutics Surprises with NarrowerThanExpected Loss in Q1 2026